http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 20 Aug 2026 07:01:25 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Aclarion+adds+University+of+Arizona+to+CLARITY+trial+network/26952651.html <p>Aclarion, Inc. (Nasdaq: ACON, ACONW) has added the University of Arizona College of Medicine – Phoenix as a clinical site in its CLARITY trial, bringing the total number of actively enrolling sites to ten, according to a company press release.</p><p>The CLARITY trial is a 300-patient, prospective, randomized, multi-center study evaluating Aclarion's Nociscan platform in patients undergoing surgical treatment for discogenic low back pain. The primary endpoint is change in back pain measured on a 100mm visual analog scale at 12 months compared to baseline. The company anticipates an initial internal data readout and public disclosure of early interim results in http://www.streetinsider.com/Corporate+News/Aclarion+adds+University+of+Arizona+to+CLARITY+trial+network/26952651.html Thu, 20 Aug 2026 07:01:25 -0400 ACON ACONW http://www.streetinsider.com/Corporate+News/Aclarion+adds+University+of+Arizona+to+CLARITY+trial+network/26952651.html <p>Aclarion, Inc. (Nasdaq: ACON, ACONW) has added the University of Arizona College of Medicine – Phoenix as a clinical site in its CLARITY trial, bringing the total number of actively enrolling sites to ten, according to a company press release.</p><p>The CLARITY trial is a 300-patient, prospective, randomized, multi-center study evaluating Aclarion's Nociscan platform in patients undergoing surgical treatment for discogenic low back pain. The primary endpoint is change in back pain measured on a 100mm visual analog scale at 12 months compared to baseline. The company anticipates an initial internal data readout and public disclosure of early interim results in http://www.streetinsider.com/Corporate+News/Aclarion+adds+University+of+Arizona+to+CLARITY+trial+network/26952651.html Thu, 20 Aug 2026 07:01:25 -0400 ACON ACONW http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Press+Releases/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html <ul><li><strong><em>University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation</em></strong></li><li><strong><em>Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain </em></strong></li><li><strong><em>Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)</em></strong><br></br></li></ul> <p align="justify">BROOMFIELD, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MlqsTK8HOphM9qUrlaSZrDSPQrcwFjEVtchkbyeNVxr4M9OcvD8D018X2NyeutepAVPppj3yeh4SbitZOTv0tw==" rel="nofollow" target="_blank">Aclarion, Inc</a>., http://www.streetinsider.com/Globe+Newswire/Aclarion+Announces+Addition+of+University+of+Arizona+College+of+Medicine+%E2%80%93+Phoenix+as+CLARITY+Trial+Site/26952621.html Thu, 20 Aug 2026 07:00:00 -0400 A.07784124 A.08435063 ACON ACONW O.00073229 O.20032280 O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+17++Filed+by%3A+Williams+Amanda+M/26947646.html si-local-file:///var/storage/secattach/20260819/26947646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+17++Filed+by%3A+Williams+Amanda+M/26947646.html Wed, 19 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+17++Filed+by%3A+Williams+Amanda+M/26947646.html si-local-file:///var/storage/secattach/20260819/26947646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+17++Filed+by%3A+Williams+Amanda+M/26947646.html Wed, 19 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+14++Filed+by%3A+Gould+Gregory+A/26941108.html si-local-file:///var/storage/secattach/20260818/26941108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+14++Filed+by%3A+Gould+Gregory+A/26941108.html Tue, 18 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+14++Filed+by%3A+Gould+Gregory+A/26941108.html si-local-file:///var/storage/secattach/20260818/26941108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+14++Filed+by%3A+Gould+Gregory+A/26941108.html Tue, 18 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Ness+Brent/26935338.html si-local-file:///var/storage/secattach/20260817/26935338.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Ness+Brent/26935338.html Mon, 17 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Ness+Brent/26935338.html si-local-file:///var/storage/secattach/20260817/26935338.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Ness+Brent/26935338.html Mon, 17 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Neal+David+K/26935344.html si-local-file:///var/storage/secattach/20260817/26935344.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Neal+David+K/26935344.html Mon, 17 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Neal+David+K/26935344.html si-local-file:///var/storage/secattach/20260817/26935344.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Neal+David+K/26935344.html Mon, 17 Aug 2026 08:30:00 -0400 ACON O.54253988 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Bond+Ryan/26935345.html si-local-file:///var/storage/secattach/20260817/26935345.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aclarion%2C+Inc.++++++++++++For%3A+Aug+13++Filed+by%3A+Bond+Ryan/26935345.html Mon, 17 Aug 2026 08:30:00 -0400 ACON O.54253988